Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
Reset all filters
01 1Malladi Drugs & Pharmaceuticals Limited
02 1Aarti Pharmalabs
03 1Believe Pharma
04 1CTX Lifesciences
05 1Curequest Lifescience
06 2Hikal Ltd.
07 3Jiangsu Zhongbang Pharmaceutical Co, Ltd
08 2Kosher Pharmaceuticals Pvt ltd
09 1LifeFirst Pharma
10 1Ocimum Labs
11 1Prajna Generics
12 1Riddhi Pharma
13 1SS Pharma
14 1Sanpra Synthesis
15 3Shamrock Medicaments
16 1Shanghai Eyougene Biotechnology Development
17 1Shree Ganesh Remedies
18 3Sigmak Lifesciences
19 3Smilax Laboratories Limited
20 4Syngenesis Chemscience Private Limited
21 1Vasudha Pharma Chem
22 3Vasudha Pharma Chem Limited
23 3Venkata Narayana Active Ingredients
24 3Vidgas Science & Technologies
25 3Zhejiang Huahai Pharmaceutical Co., Ltd.
26 2Zhuhai Rundu Pharmaceutical Co.,Ltd
Reset all filters
01 3124750-51-2
02 1124750-59-0
03 1144689-63-4
04 13144689-93-0
05 1144689-93-9
06 4144689-94-1
07 1144690-33-5
08 11144690-92-6
09 1172875-59-1
10 2189400-21-3
11 158954-23-7
12 276-83-5
13 480841-78-7
14 1CAS-124750-51-2
15 1CAS-144689-93-0
16 1CAS-144690-92-6
Reset all filters
01 9China
02 39India
Ethyl 4-(1-Hydroxy-1-methylethyl)-2-propylimidazol...
CAS Number : 144689-93-0
End Use API : Olmesartan Medoxomil
About The Company : Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufa...
Ethyl 4-(1-hydroxy-1-methyl ethyl)-2-propyl-imidaz...
CAS Number : 144689-93-0
End Use API : Olmesartan Medoxomil
About The Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, c...
4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-...
CAS Number : 144689-93-0
End Use API : Olmesartan Medoxomil
About The Company : Believe pharma is one of the leading manufacturers of APIs and its intermediates with multi-dimensional business activities. The company maintain a high standa...
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydrox...
CAS Number : 144690-92-6
End Use API : Olmesartan Medoxomil
About The Company : CTX is one of the youngest and fastest-growing Indian API and Intermediate manufacturing companies doing business in over 70 countries. In these five years, all...
5-(4'-(Bromomethyl)(1,1'-Biphenyl)-2-YL)...
CAS Number : 124750-51-2
End Use API : Olmesartan Medoxomil
About The Company : Curequest lifescience LLP is in the business of manufacturing and exports of Active Pharmaceutical Ingredients (APIs) and API Intermediates. We are a team of yo...
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[(trip...
CAS Number : 189400-21-3
End Use API : Olmesartan Medoxomil
About The Company : Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to thePharmaceu...
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(tr...
CAS Number : 144690-92-6
End Use API : Olmesartan Medoxomil
About The Company : Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to thePharmaceu...
CAS Number : 144690-92-6
End Use API : Olmesartan Medoxomil
About The Company : Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company ha...
Ethyl4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazol...
CAS Number : 144689-93-0
End Use API : Olmesartan Medoxomil
About The Company : Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company ha...
4-Chloromethyl-5-methyl-[1,3]dioxol-2-one
CAS Number : 80841-78-7
End Use API : Olmesartan Medoxomil
About The Company : Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company ha...